02.03.2016 • NewsDede Willamspatent infringementBASF

US Court Upholds BASF-Argonne NMC Patent

A US trade judge hearing a patent dispute brought last year by German chemical giant BASF and its cooperation partner Chicago-based Argonne National Laboratory, which owns the technology, has confirmed that Belgium-headquartered Umicore infringed the companies’ patents covering nickel-manganese-cobalt (NMC) cathode materials by importing their material into the United States.

Judge Thomas B. Pender of the International Trade Commission (ITC) found that the use of Umicore's NMC cathode materials in electrochemical cells or batteries by third parties in the US infringes the BASF and Argonne patents. At the same time, he rejected Umicore's arguments that the patents are invalid and unenforceable.

In its spring 2015 filing, BASF also claimed that Umicore had sold the technology to third parties, including the US arm of Japan's Makita Corporation.

BASF said at the time the patent breach had cost it billions of dollars in potential sales and deprived it of the ability to compete as a supplier for electric car platforms expected to be launched this year and next.

In its initial response to the lawsuit, Umicore called the complaint "flawed" and “erroneous.”

The Commission, which can block the import of any product deemed to infringe a US patent, now has to decide whether to review the judge's ruling. A final decision could be expected by June of this year.

Kenneth Lane, president of BASF's global catalysts division, said the German-based group is “very pleased” with the decision, which he said “provides a clear confirmation that our competitor's commercial products infringe BASF and Argonne's patented technology.”

In 2012, with investment aid from the US Department of Energy, BASF commissioned a plant at Elyria, Ohio, to produce NMC cathode precursor materials. It also conducts research and development on the battery materials in the state of Ohio.

Umicore said it remains “steadfast in its view that the scientific evidence presented in court precludes the possibility of any patent infringement and plans to present its view to the Commission.”

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
19.05.2025 • NewsChemie

OQ Chemicals firmiert künftig wieder als Oxea

Der bis Mai 2020 unter dem Namen Oxea bekannte Hersteller von Oxo-Zwischenprodukten und Oxo-Derivaten, der zwischenzeitlich zum Omanischen Energieunternehmen OQ gehörte und unter dem Namen OQ Chemicals firmierte, kehrt zu seinem alten Namen und seinen Wurzeln zurück.

Photo
08.08.2025 • News

Carbios und Indorama kooperieren bei rPET

Carbios wird recycelte Monomere bereitstellen, die von Indorama Ventures zu Filamenten für die Verstärkung von Reifen des Herstellers Michelin verarbeitet werden.